UMU logo

MIMS researchers met members of the VU LSC EMBL node

On 6th April, 2022, members of MIMS participated at an online meeting with the director and group leaders of the Vilnius University Life Sciences Center (VU LSC)-EMBL Partnership for Genome Editing Technologies. The aim of the meeting was to strengthen the connection between the MIMS, the Swedish node within the Nordic EMBL Partnership, and VU LSC, EMBL node since 2020, and identify initial matching points for future collaborations. 

VU LSC MIMS Meeting Picture3

Picture: A screenshot showing some of the participants and the starting slide of the presentation given by Lina Malinauskaité, group leader at VU LSC. Credit: Nóra Lehotai.

During the meeting, the directors provided information about the history of their nodes and their missions in research, followed by group leaders presenting their research. Each short talk gave life to lively discussion and potential collaboration ideas were born. The meeting is hopefully can be followed up with in person visits and exchanges in 2022/23. 


Director of VU LSC-EMBL node: Professor Virginijus Siksnys


To learn more about VU LSC-EMBL Partnership for Genome Editing Technologies, go to:

Emmanuelle Charpentier took the Nobel Prize in Chemistry

Emmanuelle has been awarded jointly with Jennifer Doudna the 2020 Nobel Prize in Chemistry for discovering the groundbreaking CRISPR-Cas9 gene editing technology. She is a former group leader at MIMS, honorary doctor at Umeå University and former visiting professor at UCMR.

Movie by Knut and Alice Wallenberg Foundation (

Battling antibiotic resistance

movie by Knut and Alice Wallenberg Foundation, with participation of scientists from MIMS and UCMR:
Or watch the original movie on:

Research about infectious diseases:

Oliver Billker in movie of Knut and Alice Wallenberg Foundation:
Or watch the original movie on:

footer all slides 2014-02-06

Copyright © 2019 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.